HME News talks to some home health market experts about American HomePatient's deal to go private. The consensus: Buyer Highland Capital Management is likely to be as patient in managing the new HomePatient as it was in restructuring its debt.

"It's a real quandary, because it's a great business, and it's not going anywhere from a demographics standpoint, but it has a huge cloud over it due to competitive bidding and the oxygen cap," Leonard said. "Until that cloud goes away, for many investors, the best strategy is to continue to own the company and make a little bit of money each month, because the market doesn't allow for that big payday right now."